MASCC

Reminder: The Fred Hutchinson Cancer Center (@fredhutch) is recruiting a full-time faculty member at the Assistant, Associate, or Full Professor level to join the Cancer Survivorship Program and help grow its research portfolio. Learn more on our website: mascc.org/new-position-a…

There’s still time to register for our next MASCC webinar: The Hidden Burden: Understanding and Treating Cancer Fatigue Date: May 21, 2026 Register: us02web.zoom.us/webinar/regist… All registered participants will receive a copy of the recording after the live webinar.

Watch the recording from our recent webinar: Optimizing CINV Management: Best Practices for Addressing Delayed Nausea with T-DXd vimeo.com/1190513524 This webinar is supported by an independent educational grant from  Daiichi Sankyo

mCRPC management is evolving. Join Dr Teresa Alonso Gordoa in a CME activity on dual EZH2/AR inhibition in NEPC and emerging clinical evidence. Watch now: touchoncologyime.org/dual-ezh2-ar-i…

Join us for an upcoming MASCC webinar: The Role of Biosimilars in Expanding Access and Sustainability Date: Thursday, June 11, 2026 Register: us02web.zoom.us/webinar/regist…

The patient advocate pillar of ASCO PallOnc CoP will present our initiative (approximately 5:25-5:45pm) to access US pharmacovigilance resources in collaboration with patient partners from @CancerCareMASCC and other patient advocates, as well as clinical & research stakeholders.

The National Academy of Medicine and our Italian affiliate NICSO are hosting "Oncovision 2026: Supportive Therapies at the Center of the Care Pathway for Oncology Patients", taking place online from May 18 - 19. Register here by May 15: form.jotform.com/261163588587370

Are you attending #MASCC26? Sign up for our walk/run and help raise money for the MASCC Foundation! Date: Thursday, June 25, 2026 Time: 6:15 AM - 7:30 AM Distance: 5 km Register: docs.google.com/forms/d/e/1FAI… Donate: mygoodness.benevity.org/community/caus…

The Fred Hutchinson Cancer Center (@fredhutch) is recruiting a full-time faculty member at the Assistant, Associate, or Full Professor level to join the Cancer Survivorship Program and help grow its research portfolio. Learn more on our website: mascc.org/new-position-a…

On May 16, our partner AWGHO will be hosting their first scientific meeting, taking place at the Radisson Blu Tunis in Tunisia. Learn more or register here: awgho.com

A new open-access publication from our Antiemetics and Emerging Toxicities Study Groups and led by @RonaldCChow and colleagues looks at the prevalence of ADC–induced nausea and vomiting in patients with cancer. Read the full paper here: link.springer.com/article/10.100…

Oncovision 2026 will take place online from May 18 - 19, hosted by our affiliate NICSO and the National Academy of Medicine. Register here by May 15: form.jotform.com/261163588587370 The conference will be held in Italian; however simultaneous translation will be provided.

@DrN_CancerPCP highlighted @CancerCareMASCC @ASCO guideline on survivorship care for people w advanced/metastatic cancer: 🔹 Routine, longitudinal needs assessment 🔹 Multidisciplinary, coordinated care 🔹 Inclusion of caregivers 🔹 Focus on quality of life across the trajectory

There’s still time to register for our next webinar: Optimizing CINV Management: Best Practices for Addressing Delayed Nausea with T-DXd Speakers: @maryam_lustberg Dr. George Dranitsaris Dr. Rudolph M. Navari @AMJohnston1315 Register: us02web.zoom.us/webinar/regist…

PDAC care is rapidly evolving. Hear Dr Eileen O’Reilly, Dr Michel Ducreux & Dr Thomas Hope @thomashopemd discuss current challenges, emerging therapies and what’s next for clinical practice. 🎓 Earn CME credits 👉 touchoncologyime.org/future-pdac-ca…

The Leonard P. Zakim Center for Integrative Therapies and Healthy Living (Zakim Center) at @DanaFarber Cancer Institute is searching for a new Medical Director. Visit our website to learn more, including how to apply: mascc.org/new-position-l…

The OncoAlert Colloquium is now EASIER than ever to access. We’re SHARING DIRECT VIDEO LINKS — 🚫NO password,🚫NO registration — JUST CLICK HERE& WATCH‼️ ALL LINKS HERE 👇️ 👇️ 👇️ 👇️ 👉 GU Oncology : Year in Review buff.ly/TMftfF3 👉Breast Oncology: Year in Review buff.ly/mKEsGl6 👉GI Oncology: Year in Review buff.ly/jKUzrfJ 👉GynOncology: Year in Review buff.ly/X3J3191 👉Thoracic Oncology: Year in Review buff.ly/xzDXgpe 👉Melanoma, Hematology, Lymphoma & H&N: Year in Review buff.ly/UY8CX82 This is your BEST OF THE YEAR REVIEW, featuring a world-class faculty delivering concise, high-impact updates in oncology. Each talk is under 15 minutes and concludes with clear takeaways on what has changed in clinical practice. #BreastCancer @hoperugo🇺🇸 @matteolambe🇮🇹 @Icro_Meattini🇮🇹 Dr. Roberto Salgado 🇧🇪 @ErikaHamilton9 🇺🇸 @DrSGraff 🇺🇸 @itrisabel🇪🇸 @ESSOnews @ElisaAgostinett 🇧🇪 @RebeccaDSing 🇸🇬 @LazarPo31787807 🇷🇸 #LungCancer @GlopesMd🇺🇸 @jillfeldman4 🇺🇸 @UmbertoMalapel1 🇮🇹 @BRicciutiMD 🇺🇸 @UOzkerim 🇹🇷 @DrMirallas🇺🇸 GU Oncology @brian_rini 🇺🇸 @declangmurphy 🇦🇺 @KidneyCancer🇺🇸 @salvolarosa @Silke_Gillessen🇨🇭 @RenuEapen🇦🇺 @nataliagandur 🇦🇷 @seanmcbride 🇺🇸 @jAvallejo 🇪🇸@GuardConsortium GI Oncology @CathyEngMD 🇺🇸 @BenWestphalen 🇩🇪 @graokane 🇮🇪 @GIMedOnc🇺🇸 @NiuSanford 🇺🇸 @ARosen380 🇺🇸 @Erman_Akkus 🇹🇷 @realbowtiedoc 🇺🇸 H&N @PaulJiL 🇬🇧 Heme & Lymphoma @DrJasonWestin 🇺🇸Lymphoma @FadiHaddad_MD 🇺🇸Leukemia @Abdallah81MD 🇺🇸Multiple Myeloma @NassifElise 🇺🇸Sarcoma Melanoma @DrBetofMDPhD 🇺🇸 GynOnc @NicoloBizzarri 🇮🇹Vanda Salutari 🇮🇹 @AStrojnaMD 🇩🇪Alejandra Martinez 🇫🇷 @CoquardRay 🇫🇷Christina Fotopoulou 🇬🇧Giorgia Garganesse 🇮🇹 @ChargariC 🇫🇷 Our Partners @ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg

The #OncoAlertColloquium 2026 Thoracic Malignancies🚨 DAY FIVE Presentation by Dr. Gilberto Lopes🇺🇸 : Year in Review Early #NSCLC WATCH NOW, NO REGISTRATION👉 buff.ly/hqSd5tp Practice-changing research in 2025 in early NSCLC 🚀 ✔️ Clearer insights on neoadjuvant vs adjuvant immunotherapy + chemo, with growing OS benefit ✔️ Alectinib & osimertinib now firmly established as adjuvant standards ✔️ SBRT validated for selected small stage I tumors ✔️ RiskReveal enables genomic risk stratification in early-stage disease 🧬 🔑 Take-home: early NSCLC is moving fast toward precision, personalization, and de-escalation where appropriate. #LungCancer @GlopesMd🇺🇸 @jillfeldman4 @EGFRResisters🇺🇸 @UmbertoMalapel1 🇮🇹 @isliquidbiopsy @BRicciutiMD 🇺🇸 @UOzkerim 🇹🇷 @gerryhanna @ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg @acampsmalea @HHorinouchi @FernandoOnco @ElisaAgostinett @to_be_elizabeth @bavilima @realbowtiedoc @Lucarecco @GaiaGriguolo @JankovicK @MarioBalsaMD @DrMirallas @GIMedOnc @OscarTahuahua @DrRishabhOnco @Onco_Cifu88 @PaulJiL @DaisukeKotani @DraMartinezLago @matteolambe @Icro_Meattini @GlopesMd @NarjustFlorezMD @StephenVLiu @JackWestMD @bmassutis @peters_solange @christine_lovly @bensolomon1 @VanitaNoronha @DrSanjayPopat @DrJNaidoo @MartinReck2 @Latinamd @JulienMazieres @nataliagandur

Join us for an upcoming MASCC webinar: The Hidden Burden: Understanding and Treating Cancer Fatigue Date: May 21, 2026 Speakers: @maryam_lustberg @AMJohnston1315 @amber_kleckner @stemagno74 Register: us02web.zoom.us/webinar/regist…

🌎Climate change impacts cancer care! 🌡️🌬️🚑 Extreme heat, air pollution, disasters leading to care disruptions place individuals w/cancer at ⬆️ risk! @oncologynursing lead through education, advocacy, preparation & sustainability ♻️🌱 #EarthDay